Tivozanib

Fotivda 890 Microgramos Capsulas Duras

1 mg cápsula duraSpainMarketedAuthorised 8 Apr 2018

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Authorised centrally in the EU

This national listing belongs to a medicine the European Commission authorised for the whole EU.

FotivdaEuropean UnionAuthorised

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Tivozanib

Fotivda 890 Microgramos Capsulas Duras

1 mg cápsula duraSpainMarketedAuthorised 8 Apr 2018

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Authorised centrally in the EU

This national listing belongs to a medicine the European Commission authorised for the whole EU.

FotivdaEuropean UnionAuthorised

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

FOTIVDA 890 microgrameRomania · 890 micrograme · caps. · Eusa Pharma ( Netherlands) B.V.

FotivdaUnited States · 0.89MG BASE, 1.34MG BASE · capsule · Aveo Pharms

TivozanibUnited States · 1.34MG · capsule · Sandoz INC

Packs

Pack	Code	Status
FOTIVDA 890 MICROGRAMOS CAPSULAS DURAS, 21 cápsulas	720952

Documents

The official texts, at the regulator.

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required · Added 12 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Tivozanib
Strength: 1 mg
Dosage form: cápsula dura
Route: vía oral
Register: Spain (AEMPS)
Status: Marketed
Status in the register: Autorizado, comercializado
Authorised: 8 Apr 2018
Registration: 1171215001
Marketing authorisation holder: Recordati Netherlands B.V.
Procedure: EU centralised
Supply: Diagnóstico Hospitalario
EU number: EU/1/17/1215